A GHRH analog sold in two forms that behave very differently in research.
"CJC-1295" is used for two different compounds, and the difference matters when you read a study or a COA.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). It is built from the first 29 amino acids of GHRH, with substitutions that make it more resistant to enzymatic breakdown.
DAC stands for "drug affinity complex," a chemical group that lets the peptide bind to albumin in the blood. This extends its half-life from minutes to days in the published research, and it is studied for sustained GHRH receptor signalling.
Without DAC the half-life is short, roughly 30 minutes, and it is studied for brief, pulse-like signalling.
The two forms are not interchangeable. Which one a study uses determines the signalling pattern it examines. Read the GHRH vs ghrelin explainer → and what is Ipamorelin?
All of the above is research context. CJC-1295 supplied by Midas is for laboratory research use only and is not for human consumption.
Check that the COA names the exact form (DAC or no DAC) along with HPLC purity and mass-spec identity. Here is how to read one.
View CJC-1295 research compound →